Supplements and Featured Publications
The Clinical and Economic Impact of Pneumococcal Disease in the Pediatric Population
Volume: 5
Issue: 17 Suppl
Consensus Statement: Establishing Reimbursement Guidelines for PnC7, A New Pediatric Vaccine for St
Volume: 5
Issue: 16 Suppl
The Appropriate Use of Antibiotic Therapy
Volume: 5
Issue: 15 Suppl
New Treatments for Rheumatoid Arthritis: A Managed Care Perspective
Volume: 5
Issue: 14 Suppl
Clinical and Economic Considerations of Depression Management: A Managed Care Approach
Volume: 5
Issue: 13 Suppl
Vascular Compliance: Clinical and Managed Care Issues
Volume: 5
Issue: 12 Suppl
Clinical Management of Respiratory Infections: Healthcare Decisions in an Age of Increasing Pathoge
Volume: 5
Issue: 11 Suppl
Community-Acquired Pneumonia: Achieving Optimal Outcomes in Antimicrobial Therapy
Volume: 5
Issue: 9 Suppl
Evaluating the Health Benefits of Atypical Agents in the Treatment and Management of Psychoses
Volume: 5
Issue: 10 Suppl
Clinical and Economic Opportunities of Anti-TNF Therapies in Rheumatoid Arthritis
Volume: 5
Issue: 8 Suppl
Clinical Benefits of Combination Therapy in Managing Hypertension: A Paradigm for Managed Care
Volume: 5
Issue: 7 Suppl
Clinical and Economic Impact of Breast Cancer Treatment and Prevention in High-Risk Women
Volume: 5
Issue: 6 Suppl
Creating an Optimal Strategy for Treating Endometriosis and Chronic Pelvic Pain
Volume: 5
Issue: 5 Suppl
A Multidisciplined Approach to Improving the Treatment of Allergic Rhinitis in the Managed Care Popu
Volume: 5
Issue: 4 Suppl
Use of Selective Estrogen Receptor Modulators among Postmenopausal Women in the Managed Care Setting
Volume: 5
Issue: 3 Suppl
Clinical and Therapeutic Advances in Migraine Management: A Managed Care Perspective
Volume: 5
Issue: 2 Suppl
Clinical and Therapeutic Advances in the Treatment of Sexual Dysfunction: A Paradigm for Managed Ca
Volume: 5
Issue: 1 Suppl
Advertisement
Advertisement
Trending on AJMC
1
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
2
Advancing Early Detection and Equitable Access in Alzheimer Disease Care
3
ICYMI: Highlights From SPD 2025
4
In CLL, New Therapies Offer Potential for Personalized Approaches
5
